These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36496261)

  • 21. [How to reduce lung cancer mortality among people living with HIV?].
    Ruppert AM; Lavolé A; Makinson A; Le Maître B; Cadranel J
    Rev Mal Respir; 2020 Mar; 37(3):267-274. PubMed ID: 32197931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in Italy?
    Carreras G; Gorini G; Paci E
    Cancer Prev Res (Phila); 2012 Jun; 5(6):874-82. PubMed ID: 22525583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A; Fontaine M; Galloula A; Damotte D; Chatellier G; Paterlini-Bréchot P; Meyer G; Pastre J; Duchatelle V; Marini V; Schwering KL; Lazareth I; Ghaffari P; Stansal A; Sanson H; Labrousse C; Beaussier H; Nasr NB; Zins M; Salmeron S; Messas E; Lajonchère JP; Emmerich J; Priollet P; Trédaniel J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):212. PubMed ID: 31519196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for lung cancer. Too many uncertainties, even for smokers.
    Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Leleu O; Basille D; Auquier M; Clarot C; Hoguet E; Pétigny V; Addi AA; Milleron B; Chauffert B; Berna P; Jounieaux V
    Clin Lung Cancer; 2020 Mar; 21(2):145-152. PubMed ID: 31982356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
    Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
    Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
    Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
    BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer screening as a teachable moment for smoking cessation.
    Taylor KL; Cox LS; Zincke N; Mehta L; McGuire C; Gelmann E
    Lung Cancer; 2007 Apr; 56(1):125-34. PubMed ID: 17196298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.
    Taylor KL; Deros DE; Fallon S; Stephens J; Kim E; Lobo T; Davis KM; Luta G; Jayasekera J; Meza R; Stanton CA; Niaura RS; Abrams DB; McKee B; Howell J; Ramsaier M; Batlle J; Dornelas E; Parikh V; Anderson E
    Contemp Clin Trials; 2019 Jul; 82():25-35. PubMed ID: 31129371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European and North American lung cancer screening experience and implications for pulmonary nodule management.
    Nair A; Hansell DM
    Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer screening: does pulmonary nodule detection affect a range of smoking behaviours?
    Clark ME; Young B; Bedford LE; das Nair R; Robertson JFR; Vedhara K; Sullivan F; Mair FS; Schembri S; Littleford RC; Kendrick D
    J Public Health (Oxf); 2019 Sep; 41(3):600-608. PubMed ID: 30272192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose computed tomography screening reduces lung cancer mortality.
    Ostrowski M; Marjański T; Rzyman W
    Adv Med Sci; 2018 Sep; 63(2):230-236. PubMed ID: 29425790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AHRR (cg05575921) Methylation Safely Improves Specificity of Lung Cancer Screening Eligibility Criteria: A Cohort Study.
    Jacobsen KK; Schnohr P; Jensen GB; Bojesen SE
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):758-765. PubMed ID: 35064064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.